Timeline

Rafael Machado

Post-doc

24 Feb 2024

publication

Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome.

01 Feb 2024

publication

Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.

30 Jan 2024

publication

Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster.

17 Jul 2023

publication

Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.

28 Feb 2023

publication

Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests.

28 Dec 2022

publication

Primary and Secondary Attack Rates by Vaccination Status after a SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak at a Youth Summer Camp-Texas, June 2021.

18 Sep 2022

publication

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.

13 Aug 2022

publication

Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes.

11 Aug 2022

publication

Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease.

01 Jun 2022

publication

Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI).

01 May 2022

publication

A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants.

09 Feb 2022

publication

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection.

01 Feb 2022

publication

Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.

01 Jan 2022

publication

Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.

01 Jan 2022

publication

Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.

01 Jan 2022

publication

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.

23 Dec 2021

publication

Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial.

01 Dec 2021

publication

Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?

08 Oct 2021

publication

Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells.

07 Oct 2021

publication

Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.

01 Oct 2021

publication

Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.

28 Sep 2021

publication

Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.

01 Aug 2021

publication

COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.

01 May 2021

publication

Anti-A and SARS-CoV-2: an intriguing association.

01 May 2021

publication

A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.

30 Apr 2021

publication

Neonatal consequences of maternal exposure to the chikungunya virus: Case reports.

01 Apr 2021

publication

Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.

01 Jan 2021

publication

Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome.

01 Dec 2020

publication

Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.

01 Dec 2020

publication

UV-C (254 nm) lethal doses for SARS-CoV-2.

01 Oct 2020

publication

Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.

01 Sep 2020

publication

Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR.

01 Jan 2020

publication

SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network.

01 Jan 2020

publication

Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from Brazil.

01 Jan 2020

publication

Zika virus seroprevalence in blood donors from the Northeastern region of São Paulo State, Brazil, between 2015 and 2017.

01 Mar 2019

publication

Zika Virus in Peridomestic Neotropical Primates, Northeast Brazil.

19 Jan 2018

team

Evolutionary genomics of RNA viruses

01 Jan 2018

publication

A little guide for advanced search:

Timeline

Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome.

Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.

Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster.

Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.

Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests.

Primary and Secondary Attack Rates by Vaccination Status after a SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak at a Youth Summer Camp-Texas, June 2021.

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.

Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes.

Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease.

Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI).

A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants.

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection.

Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.

Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.

Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.

Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial.

Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?

Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells.

Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.

Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.

Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.

COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.

Anti-A and SARS-CoV-2: an intriguing association.

A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.

Neonatal consequences of maternal exposure to the chikungunya virus: Case reports.

Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.

Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome.

Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.

UV-C (254 nm) lethal doses for SARS-CoV-2.

Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.

Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR.

SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network.

Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from Brazil.

Zika virus seroprevalence in blood donors from the Northeastern region of São Paulo State, Brazil, between 2015 and 2017.

Zika Virus in Peridomestic Neotropical Primates, Northeast Brazil.

Evolutionary genomics of RNA viruses

Lack of serological and molecular evidence of arbovirus infections in bats from Brazil.